Sara Khan1, Divya Shridharmurthy2,3, Kate L Lapane2, Catherine Dube2, Jonathan Kay2,4,5, Esther Yi6, Shao-Hsien Liu2,5. 1. Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, 01605, USA. Sara.Khan@umassmed.edu. 2. Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, 01605, USA. 3. Clinical and Population Health Research Program, Morningside Graduate School of Biomedical Sciences, UMass Chan Medical School, Worcester, MA, 01655, USA. 4. Division of Rheumatology, UMass Memorial Medical Center, Worcester, MA, 01605, USA. 5. Division of Rheumatology, Department of Medicine, UMass Chan Medical School, Worcester, MA, 01605, USA. 6. Novartis Pharmaceuticals Corporation, 59 State Route 10, East Hanover, NJ, 07936, USA.
Abstract
INTRODUCTION: Axial spondyloarthritis (axSpA) affects patients' health-related quality of life (HRQoL). Prior studies have documented gender differences in axSpA across the disease spectrum. Our study aims to assess gender differences on the effects of axSpA on patients' HRQoL. METHOD: A secondary qualitative thematic analysis was conducted using data from in-depth interviews (n = 24) of patients with a rheumatologist-confirmed axSpA diagnosis. This analysis focused on gender and HRQoL themes including activity, occupation, sleep, healthcare system, mental health, medication usage, and relationships. RESULTS: While men on average waited a year longer than women to tell healthcare providers about symptoms (2.5 years men versus 1.6 years women), the interval between first report of symptoms to diagnosis was ~ 2 years longer for women relative to men (7.5 women versus 9.3 years men). Women and men with axSpA shared more similarities than differences regarding the impact of disease on HRQoL including (1) physical health, (2) limited mobility, (3) occupation, (4) sleep, (5) healthcare system obstacles, (6) mental health, (7) medication usage, and (8) relationships. Some women reported being dismissed by doctors due to their gender, and some described the pain experienced during pregnancy and complications during birth. CONCLUSIONS: axSpA adversely impacts HRQoL regardless of gender, but women seeking care for axSpA may experience greater challenges reaching a diagnosis. It is essential that providers recognize impaired HRQoL among men and women with axSpA. Future studies with larger sample sizes are needed to identify aspects of HRQoL to adequately address people with axSpA. Key Points • While men waited on average a year longer to tell their healthcare provider about their symptoms, the diagnostic delay is 2 years longer for women. • Women and men with axSpA have similar experiences regarding impacts on their health-related quality of life. • Some women describe difficulty during pregnancy and being dismissed by doctors due to their gender.
INTRODUCTION: Axial spondyloarthritis (axSpA) affects patients' health-related quality of life (HRQoL). Prior studies have documented gender differences in axSpA across the disease spectrum. Our study aims to assess gender differences on the effects of axSpA on patients' HRQoL. METHOD: A secondary qualitative thematic analysis was conducted using data from in-depth interviews (n = 24) of patients with a rheumatologist-confirmed axSpA diagnosis. This analysis focused on gender and HRQoL themes including activity, occupation, sleep, healthcare system, mental health, medication usage, and relationships. RESULTS: While men on average waited a year longer than women to tell healthcare providers about symptoms (2.5 years men versus 1.6 years women), the interval between first report of symptoms to diagnosis was ~ 2 years longer for women relative to men (7.5 women versus 9.3 years men). Women and men with axSpA shared more similarities than differences regarding the impact of disease on HRQoL including (1) physical health, (2) limited mobility, (3) occupation, (4) sleep, (5) healthcare system obstacles, (6) mental health, (7) medication usage, and (8) relationships. Some women reported being dismissed by doctors due to their gender, and some described the pain experienced during pregnancy and complications during birth. CONCLUSIONS: axSpA adversely impacts HRQoL regardless of gender, but women seeking care for axSpA may experience greater challenges reaching a diagnosis. It is essential that providers recognize impaired HRQoL among men and women with axSpA. Future studies with larger sample sizes are needed to identify aspects of HRQoL to adequately address people with axSpA. Key Points • While men waited on average a year longer to tell their healthcare provider about their symptoms, the diagnostic delay is 2 years longer for women. • Women and men with axSpA have similar experiences regarding impacts on their health-related quality of life. • Some women describe difficulty during pregnancy and being dismissed by doctors due to their gender.
Authors: Hellen M S de Carvalho; Adriana B Bortoluzzo; Célio R Gonçalves; José Antonio Braga da Silva; Antonio Carlos Ximenes; Manoel B Bértolo; Sandra L E Ribeiro; Mauro Keiserman; Rita Menin; Thelma L Skare; Sueli Carneiro; Valderílio F Azevedo; Walber P Vieira; Elisa N Albuquerque; Washington A Bianchi; Rubens Bonfiglioli; Cristiano Campanholo; Izaias P Costa; Angela P Duarte; Maria Bernadete O Gavi; Charles L Kohem; Nocy H Leite; Sonia A L Lima; Eduardo S Meirelles; Ivânio A Pereira; Marcelo M Pinheiro; Elizandra Polito; Gustavo G Resende; Francisco Airton C Rocha; Mittermayer B Santiago; Maria de Fátima L C Sauma; Percival D Sampaio-Barros Journal: Clin Rheumatol Date: 2011-12-28 Impact factor: 2.980
Authors: Alexis Ogdie; Taylor Blachley; Paul R Lakin; Blessing Dube; Robert R McLean; Peter Hur; Philip J Mease Journal: J Rheumatol Date: 2021-12-01 Impact factor: 4.666
Authors: Casper Webers; Ivette Essers; Sofia Ramiro; Carmen Stolwijk; Robert Landewé; Désirée van der Heijde; Filip van den Bosch; Maxime Dougados; Astrid van Tubergen Journal: Rheumatology (Oxford) Date: 2015-09-18 Impact factor: 7.580
Authors: Margarita Landi; Hernán Maldonado-Ficco; Rodolfo Perez-Alamino; José A Maldonado-Cocco; Gustavo Citera; Pablo Arturi; Percival D Sampaio-Barros; Diana E Flores Alvarado; Rubén Burgos-Vargas; Elena Santos; Daniel Palleiro; Miguel A Gutiérrez; Elsa Vieyra-Sousa; Fernando Pimentel-Santos; Sergio O Paira; Alberto Berman; Claudia Vera Barrezueta; Janitzia Vazquez-Mellado; Eduardo Collantes-Estevez Journal: Medicine (Baltimore) Date: 2016-12 Impact factor: 1.889
Authors: Diego Benavent; Dafne Capelusnik; Sofia Ramiro; Anna Molto; Clementina López-Medina; Maxime Dougados; Victoria Navarro-Compán Journal: RMD Open Date: 2022-09